Bepirovirsen is an antisense oligonucleotide targeting all HBV messenger RNAs. Bepirovirsen leads to reductions in HBV-derived RNAs, HBV DNA and viral proteins. Bepirovirsen can be used for the research of chronic HBV infection. Bepirovirsen binding site sequence (GCACTTCGCTTCACCTCTGC).
Bepirovirsen is an antisense oligonucleotide targeting all HBV messenger RNAs. Bepirovirsen leads to reductions in HBV-derived RNAs, HBV DNA and viral proteins. Bepirovirsen can be used for the research of chronic HBV infection. Bepirovirsen binding site sequence (GCACTTCGCTTCACCTCTGC).
体外研究
Bepirovesen (16-250 nM; 16 hours) can reduce hepatitis B virus (HBV) RNA, DNA, and viral proteins in HepG2.2.15 cells.
体内研究
Bepirovesen (22-50 mg/kg/week; Subcutaneous injection, twice a week in the first week and once a week in the second to fourth weeks, can reduce HBV RNA and DNA in the liver of HBV transgenic mice.
Animal Model:
Male HBV transgenic mice (Tg[HBV 1.3 genome]Chi32 against C57BL/6 background) aged 7-12 weeks and weight 18-25 g.
Dosage:
22, 50 mg/kg/week
Administration:
Injected subcutaneously twice weekly for week 1 and once weekly for weeks 2-4
Result:
Dose-dependently reduced hepatic levels of HBV DNA and HBV RNA in HBV transgenic mice.
Reduced levels of serum HBV DNA, serum HBsAg and serum HBeAg.
分子量
7344
CAS号
1403787-62-1
运输条件
Room temperature in continental US; may vary elsewhere.